Cargando…

Hippo Pathway in Regulating Drug Resistance of Glioblastoma

Glioblastoma (GBM) represents the most common and malignant tumor of the Central Nervous System (CNS), affecting both children and adults. GBM is one of the deadliest tumor types and it shows a strong multidrug resistance (MDR) and an immunosuppressive microenvironment which remain a great challenge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casati, Giacomo, Giunti, Laura, Iorio, Anna Lisa, Marturano, Arianna, Galli, Luisa, Sardi, Iacopo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705144/ https://www.ncbi.nlm.nih.gov/pubmed/34948224 http://dx.doi.org/10.3390/ijms222413431

Ejemplares similares

Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
por: Da Ros, Martina, et al.
Publicado: (2018)

The Hippo Signaling Pathway in Drug Resistance in Cancer
por: Zeng, Renya, et al.
Publicado: (2021)

Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
por: Da Ros, Martina, et al.
Publicado: (2018)

Combined Treatment with Doxorubicin and Rapamycin Is Effective against In Vitro and In Vivo Models of Human Glioblastoma
por: Iorio, Anna Lisa, et al.
Publicado: (2019)

Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma
por: Iorio, Anna Lisa, et al.
Publicado: (2017)

A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
por: Giunti, Laura, et al.
Publicado: (2019)

Upstream regulators of the Hippo pathway
por: Yu, Fa-Xing, et al.
Publicado: (2012)

Mechanisms of Hippo pathway regulation
por: Meng, Zhipeng, et al.
Publicado: (2016)

Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
por: Kaur, Simran, et al.
Publicado: (2021)

Diversity in function and regulation of the Hippo pathway
por: Zhou, Dawang
Publicado: (2013)

Histone Acetylation-Mediated Regulation of the Hippo Pathway
por: Basu, Dipanjan, et al.
Publicado: (2013)

The Spectrin cytoskeleton regulates the Hippo signalling pathway
por: Fletcher, Georgina C, et al.
Publicado: (2015)

Regulation of the Hippo signaling pathway by ubiquitin modification
por: Kim, Youngeun, et al.
Publicado: (2018)

Mechanical strain regulates the Hippo pathway in Drosophila
por: Fletcher, Georgina C., et al.
Publicado: (2018)

The Regulation of the Hippo Pathway by Intercellular Junction Proteins
por: Ahmad, Usama Sharif, et al.
Publicado: (2022)

Emerging role of Hippo pathway in the regulation of hematopoiesis
por: Kim, Inyoung, et al.
Publicado: (2023)

Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas
por: Kim, Eui Hyun, et al.
Publicado: (2020)

Bazedoxifene enhances paclitaxel efficacy to suppress glioblastoma via altering Hippo/YAP pathway
por: Fu, Weiwei, et al.
Publicado: (2020)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
por: Escoll, Maribel, et al.
Publicado: (2020)

Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
por: Watt, Kevin I., et al.
Publicado: (2017)

Regulation of the Hippo signaling pathway by deubiquitinating enzymes in cancer
por: Mussell, Ashley, et al.
Publicado: (2019)

Roles of Membrane and Vesicular Traffic in Regulation of the Hippo Pathway
por: Verghese, Shilpi, et al.
Publicado: (2020)

Calcium, an Emerging Intracellular Messenger for the Hippo Pathway Regulation
por: Wei, Yiju, et al.
Publicado: (2021)

The Hippo pathway regulates axis formation and morphogenesis in Hydra
por: Brooun, Maria, et al.
Publicado: (2022)

Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
por: Liu, Jie, et al.
Publicado: (2020)

Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
por: Ferranti, Silvia, et al.
Publicado: (2021)

Drugging the Hippo (Pathway): A Strategy to Stimulate Cardiac Regeneration?
por: Mani, Kartik, et al.
Publicado: (2018)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways
por: Karvonen, Hanna, et al.
Publicado: (2019)

Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors
por: Guidi, Milena, et al.
Publicado: (2020)

The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway
por: Yang, Rui, et al.
Publicado: (2016)

CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway
por: Wang, Xin, et al.
Publicado: (2021)

The Hippo Pathway: Immunity and Cancer
por: Taha, Zaid, et al.
Publicado: (2018)

The Hippo Pathway in Prostate Cancer
por: Salem, Omar, et al.
Publicado: (2019)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

The Hippo Pathway and Viral Infections
por: Wang, Zhilong, et al.
Publicado: (2020)

Hippo Signaling Pathway in Gliomas
por: Masliantsev, Konstantin, et al.
Publicado: (2021)

The role of Hippo pathway in ferroptosis
por: Xiang, Jiangxia, et al.
Publicado: (2023)

WW domain interactions regulate the Hippo tumor suppressor pathway
por: Salah, Z, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qubt22dichrb9fs1h7ngpr9tan